<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1409-4142</journal-id>
<journal-title><![CDATA[Revista Costarricense de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. costarric. cardiol]]></abbrev-journal-title>
<issn>1409-4142</issn>
<publisher>
<publisher-name><![CDATA[Asociación Costarricense de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1409-41422022000100024</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Rehabilitación en cardiotoxicidad relacionada al cáncer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Uclés Villalobos]]></surname>
<given-names><![CDATA[Vanessa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas Chaves]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Calderón Guardia Medicina Física y Rehabilitación ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital San Rafael de Alajuela Medicina Física y Rehabilitación ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>24</fpage>
<lpage>28</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S1409-41422022000100024&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S1409-41422022000100024&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S1409-41422022000100024&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  La cardiotoxicidad relacionada al cáncer son los efectos nocivos en el corazón ocasionados por el tratamiento oncológico especialmente: agentes de quimioterapia, hormonas, radioterapia y/o inmunoterapia.  Objetivos:  Realizar una revisión sistemática de la literatura para identificar los efectos secundarios del tratamiento oncológico en el corazón potencialmente prevenibles y susceptibles a tratamiento mediante un programa de rehabilitación cardio-oncológica.  Métodos:  Se identificaron los estudios relevantes publicados entre el 1° de marzo de 2010 y el 30 de setiembre de 2019 mediante búsqueda en MEDLINE.  Resultados:  Mediante la prevención , detección temprana de la cardiotoxicidad y la instauración oportuna de un tratamiento cardioprotector se pueden revertir los efectos deletéreos del tratamiento oncológico.  Conclusiones:  La rehabilitación cardio-oncológica es una estrategia efectiva para mejorar el pronóstico , sobrevida y calidad de vida del paciente con cáncer .]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Cardiotoxicity is the harmful effect of the oncological treatment on hearth, specially chemotherapy, hormonal treatment , radiotherapy or immunotherapy.  Objectives:  The objective of this study is to undertake a systematic review of the international scientific literature to identify the effects on hearth which are potencially reversible through cardiac-oncological rehabilitation programmes.  Methods:  A MEDLINE review of the relevant literature between march 2010 and September 2019.  Results:  The early detection of cardiotoxicity allows the reversibility of the harmfull effects on hearth.  Conclusion: Cardio-oncological rehabilitation is effective in improving prognosis, quality of live and survival on cancer patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cardiotoxicidad]]></kwd>
<kwd lng="es"><![CDATA[Rehabilitación cardio-oncológica]]></kwd>
<kwd lng="es"><![CDATA[Cáncer]]></kwd>
<kwd lng="en"><![CDATA[Cardiotoxicity]]></kwd>
<kwd lng="en"><![CDATA[Cardiac-oncological rehabilitation]]></kwd>
<kwd lng="en"><![CDATA[Cancer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giallauria]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Maresca]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Vitelli]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exercise training improves heart rate recovery in women with breast cancer.]]></article-title>
<source><![CDATA[Springerplus]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>388</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cavarretta]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Positive Effects of Exercise in ChemotherapyRelated Cardiomyopathy.]]></article-title>
<source><![CDATA[Adv Exp Med Biol.]]></source>
<year>2017</year>
<volume>1000</volume>
<page-range>103-29</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Snipelisky]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How to Develop a Cardio-Oncology Clinic]]></article-title>
<source><![CDATA[Heart Fail Clin.]]></source>
<year>2017</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>347-59</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D'Ascenzi]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology]]></article-title>
<source><![CDATA[Eur J Prev Cardiol]]></source>
<year>2019</year>
<volume>28</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>725-35</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pituskin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rationale and design of the multidisciplinary team IntervenTion in cardio-oncology study (TITAN).]]></article-title>
<source><![CDATA[BMC Cancer]]></source>
<year>2016</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>733</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giza]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer as a risk factor for cardiovascular disease]]></article-title>
<source><![CDATA[Curr Oncol Rep.]]></source>
<year>2017</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>39</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hubbard]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is referral of postsurgical colorectal cancer survivors to cardiac rehabilitation feasible and acceptable? A pragmatic pilot randomised controlled trial with embedded qualitative study]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2016</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>84</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jawa]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis.]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2016</year>
<volume>95</volume>
<numero>44</numero>
<issue>44</issue>
<page-range>51</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiac complications of cancer therapy: pathophysiology, identification, prevention, treatment, and future directions]]></article-title>
<source><![CDATA[Curr Cardiol Rep]]></source>
<year>2017</year>
<volume>19</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>36</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Aronow]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiotoxicity of cancer chemotherapy in clinical practice]]></article-title>
<source><![CDATA[Hosp Prac]]></source>
<year>2019</year>
<volume>47</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-15</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lotrionte]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity.]]></article-title>
<source><![CDATA[The Am J Cardiol]]></source>
<year>2013</year>
<volume>112</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1980-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamorano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESC position paper on cancer treatments and Cardiovascular toxicitry developed under the auspices of the ESC Commitee for practice guidelines.]]></article-title>
<source><![CDATA[European Heart Journal]]></source>
<year>2016</year>
<volume>37</volume>
<numero>36</numero>
<issue>36</issue>
<page-range>2768-801</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J.M]]></given-names>
</name>
<name>
<surname><![CDATA[Nilsen]]></surname>
<given-names><![CDATA[T.S]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[L.W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exercise therapy and cardiovascular toxicity in cancer.]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2018</year>
<volume>137</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1176-91</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Biasillo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkham]]></surname>
<given-names><![CDATA[A.A]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[M.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exercise prevention of cardiovascular disease in breast cancer survivors]]></article-title>
<source><![CDATA[J Oncol.]]></source>
<year>2015</year>
<page-range>917606</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones.]]></article-title>
<source><![CDATA[Revista Española de Cardiología]]></source>
<year>2017</year>
<volume>70</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>474-86</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkham]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review.]]></article-title>
<source><![CDATA[Int J Womens Health]]></source>
<year>2015</year>
<volume>23</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>127-40</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seraphim]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Treat Options Oncol]]></source>
<year>2019</year>
<volume>20</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>73</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions]]></article-title>
<source><![CDATA[Am J Physiol Heart Circ Physiol]]></source>
<year>2017</year>
<volume>312</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>H213-22</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Repka]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer type does not affect exercise-mediated improvements in cardiorespiratory function and fatigue.]]></article-title>
<source><![CDATA[Integr Cancer Ther]]></source>
<year>2014</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>473-81</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parent]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pituskin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Paterson]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease]]></article-title>
<source><![CDATA[The Canadian Journal of Cardiology]]></source>
<year>2016</year>
<volume>32</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>847-51</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilchrist]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.]]></article-title>
<source><![CDATA[Circulation]]></source>
<year></year>
<volume>2019</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>e997-e1012</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curigliano]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiotoxicity of anticancer treatments: Epidemiology, detection and management.]]></article-title>
<source><![CDATA[Cancer Journal for Clinicians]]></source>
<year>2016</year>
<volume>66</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>309-25</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
